BOULDER, Colo.--(BUSINESS WIRE)--Feb. 14, 2013--
Clovis Oncology, Inc. (NASDAQ:CLVS) will announce its fourth
quarter/year end 2012 financial results on Thursday, February 28, 2013,
after the close of the U.S. financial markets. Clovis’ senior management
will host a conference call and live audio webcast on Thursday, February
28, at 4:30 p.m. ET to discuss the company’s results in greater detail.
The conference call is being webcast and can be accessed from the Clovis
Oncology website at www.clovisoncology.com.
A replay of the webcast will be available for 30 days.
About Clovis Oncology
Clovis Oncology, Inc. is a biopharmaceutical company focused on
acquiring, developing and commercializing innovative anti-cancer agents
in the U.S., Europe and additional international markets. Clovis
Oncology targets development programs at specific subsets of cancer
populations, and simultaneously develops diagnostic tools that direct a
compound in development to the population that is most likely to benefit
from its use. Clovis Oncology is headquartered in Boulder, Colorado, and
has additional offices in San Francisco, California, and Cambridge, UK.
Source: Clovis Oncology, Inc.
Clovis Oncology, Inc.
Anna Sussman, 303-625-5022
asussman@clovisoncology.com
Breanna
Burkart, 303-625-5023
bburkart@clovisoncology.com